The Resource Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa
Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa
Resource Information
The item Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in University of Missouri Libraries.This item is available to borrow from 1 library branch.
Resource Information
The item Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in University of Missouri Libraries.
This item is available to borrow from 1 library branch.
- Summary
- "During the past decade, remarkable progress has been made in the development of new drugs to treat thrombotic and cardiovascular diseases, the number one cause of mortality worldwide. In Anticoagulants, Antiplatelets, and Thrombolytics, leading experts with established records of discovery and invention highlight the latest developments in antithrombotics and provide experimental methods for the discovery of new and improved anticoagulants. Among the cutting-edge developments reviewed are the novel usage of low molecular weight heparins, such antithrombin agents as hirudin, and such antiplatelet drugs as the GPIIb/IIIa inhibitors and ADP-receptor antagonists. Additional innovations discussed include aspirin and clopidogrel, the expanded use of polytherapeutic approaches, antiproteases (factors IIa, Xa, and VIIa), tissue-factor targeting, platelet-receptor targeting, and antithrombin III modulation. The authors also define the clinically relevant in vitro and in vivo models of thrombosis and hemostasis that led to these advances and that will surely aid in the discovery of the next generation of antithrombotics. Up-to-date and forward-looking, Anticoagulants, Antiplatelets, and Thrombolytics illuminates the latest developments in the field of thrombosis and provides both basic and clinical investigators a broad array of successful experimental methods for the discovery and development of novel drugs to treat thrombotic and cardiovascular diseases. Book jacket."--Jacket
- Language
- eng
- Extent
- 1 online resource (x, 307 pages)
- Contents
-
- Highlights of latest advances in antithrombotics / S.A. Mousa
- Antiplatelet, anticoagulant, and thrombolytic drug interactions / O. Iqbal and S.A. Mousa
- Evaluation of platelet antagonists in in vitro flow models of thrombosis / O.J. McCarty [and others]
- Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases / S.A. Mousa
- Are low molecular weight heparins the same? / S.A. Mousa
- Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia / W.P. Jeske and J.M. Walenga
- Laboratory methods for heparin-induced thrombocytopenia / M. Prechel, W.P. Jeske and J.M. Walenga
- Factor Xa inhibitors / J.M. Walenga [and others]
- Tissue factor/VIIa in thrombosis and cancer / S.A. Mousa
- Tissue factor pathway inhibitor in thrombosis and beyond / S.A. Mousa [and others]
- Cell adhesion molecules: potential therapeutic and diagnostic implications / S.A. Mousa
- Development and applications of animal models of thrombosis / R.J. Shebuski [and others]
- A survey of venous thrombosis models / W.P. Jeske [and others]
- Arixtra (fondaparinux sodium) / S.A. Mousa
- Oral thrombin inhibitor ximelagatran / S.A. Mousa
- Pharmacogenomics and coagulation disorders / O. Iqbal
- Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism / H. Abdel-Razeq [and others]
- Isbn
- 9781592596584
- Label
- Anticoagulants, antiplatelets, and thrombolytics
- Title
- Anticoagulants, antiplatelets, and thrombolytics
- Statement of responsibility
- edited by Shaker A. Mousa
- Subject
-
- Anticoagulantia
- Anticoagulants (Medicine)
- Anticoagulants (Medicine)
- Anticoagulants (Medicine)
- Anticoagulants -- therapeutic use
- Antitrombotica
- Bloedplaatjes
- Blood platelets
- Blood platelets
- Blood platelets
- Fibrinolytic Agents -- therapeutic use
- Fibrinolytic agents
- Fibrinolytic agents
- Fibrinolytic agents
- Heparin -- therapeutic use
- MEDICAL -- Pharmacology
- Platelet Aggregation Inhibitors -- therapeutic use
- Thrombocytopenia -- drug therapy
- Thrombolytic Therapy -- methods
- Thrombolytic therapy
- Thrombolytic therapy
- Thrombolytic therapy
- Wetenschappelijke technieken
- Language
- eng
- Summary
- "During the past decade, remarkable progress has been made in the development of new drugs to treat thrombotic and cardiovascular diseases, the number one cause of mortality worldwide. In Anticoagulants, Antiplatelets, and Thrombolytics, leading experts with established records of discovery and invention highlight the latest developments in antithrombotics and provide experimental methods for the discovery of new and improved anticoagulants. Among the cutting-edge developments reviewed are the novel usage of low molecular weight heparins, such antithrombin agents as hirudin, and such antiplatelet drugs as the GPIIb/IIIa inhibitors and ADP-receptor antagonists. Additional innovations discussed include aspirin and clopidogrel, the expanded use of polytherapeutic approaches, antiproteases (factors IIa, Xa, and VIIa), tissue-factor targeting, platelet-receptor targeting, and antithrombin III modulation. The authors also define the clinically relevant in vitro and in vivo models of thrombosis and hemostasis that led to these advances and that will surely aid in the discovery of the next generation of antithrombotics. Up-to-date and forward-looking, Anticoagulants, Antiplatelets, and Thrombolytics illuminates the latest developments in the field of thrombosis and provides both basic and clinical investigators a broad array of successful experimental methods for the discovery and development of novel drugs to treat thrombotic and cardiovascular diseases. Book jacket."--Jacket
- Cataloging source
- COO
- Dewey number
- 615/.718
- Illustrations
- illustrations
- Index
- index present
- Language note
- English
- LC call number
- RM340
- LC item number
- .A566 2004
- Literary form
- non fiction
- Nature of contents
-
- dictionaries
- bibliography
- NLM call number
-
- W1
- QZ 170
- NLM item number
-
- ME9616JM v.93 2003
- A629 2003
- http://library.link/vocab/relatedWorkOrContributorName
- Mousa, Shaker A
- Series statement
- Methods in molecular medicine
- Series volume
- 93
- http://library.link/vocab/subjectName
-
- Anticoagulants (Medicine)
- Blood platelets
- Thrombolytic therapy
- Fibrinolytic agents
- Anticoagulants
- Thrombolytic Therapy
- Fibrinolytic Agents
- Heparin
- Platelet Aggregation Inhibitors
- Thrombocytopenia
- MEDICAL
- Anticoagulants (Medicine)
- Blood platelets
- Fibrinolytic agents
- Thrombolytic therapy
- Anticoagulantia
- Antitrombotica
- Bloedplaatjes
- Wetenschappelijke technieken
- Label
- Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa
- Bibliography note
- Includes bibliographical references and index
- Carrier category
- online resource
- Carrier category code
-
- cr
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type code
-
- txt
- Content type MARC source
- rdacontent
- Contents
- Highlights of latest advances in antithrombotics / S.A. Mousa -- Antiplatelet, anticoagulant, and thrombolytic drug interactions / O. Iqbal and S.A. Mousa -- Evaluation of platelet antagonists in in vitro flow models of thrombosis / O.J. McCarty [and others] -- Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases / S.A. Mousa -- Are low molecular weight heparins the same? / S.A. Mousa -- Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia / W.P. Jeske and J.M. Walenga -- Laboratory methods for heparin-induced thrombocytopenia / M. Prechel, W.P. Jeske and J.M. Walenga -- Factor Xa inhibitors / J.M. Walenga [and others] -- Tissue factor/VIIa in thrombosis and cancer / S.A. Mousa -- Tissue factor pathway inhibitor in thrombosis and beyond / S.A. Mousa [and others] -- Cell adhesion molecules: potential therapeutic and diagnostic implications / S.A. Mousa -- Development and applications of animal models of thrombosis / R.J. Shebuski [and others] -- A survey of venous thrombosis models / W.P. Jeske [and others] -- Arixtra (fondaparinux sodium) / S.A. Mousa -- Oral thrombin inhibitor ximelagatran / S.A. Mousa -- Pharmacogenomics and coagulation disorders / O. Iqbal -- Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism / H. Abdel-Razeq [and others]
- Control code
- 170925939
- Dimensions
- unknown
- Extent
- 1 online resource (x, 307 pages)
- Form of item
- online
- Isbn
- 9781592596584
- Media category
- computer
- Media MARC source
- rdamedia
- Media type code
-
- c
- Other control number
- 10.1385/1592596584
- Other physical details
- illustrations.
- Specific material designation
- remote
- System control number
- (OCoLC)170925939
- Label
- Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa
- Bibliography note
- Includes bibliographical references and index
- Carrier category
- online resource
- Carrier category code
-
- cr
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type code
-
- txt
- Content type MARC source
- rdacontent
- Contents
- Highlights of latest advances in antithrombotics / S.A. Mousa -- Antiplatelet, anticoagulant, and thrombolytic drug interactions / O. Iqbal and S.A. Mousa -- Evaluation of platelet antagonists in in vitro flow models of thrombosis / O.J. McCarty [and others] -- Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases / S.A. Mousa -- Are low molecular weight heparins the same? / S.A. Mousa -- Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia / W.P. Jeske and J.M. Walenga -- Laboratory methods for heparin-induced thrombocytopenia / M. Prechel, W.P. Jeske and J.M. Walenga -- Factor Xa inhibitors / J.M. Walenga [and others] -- Tissue factor/VIIa in thrombosis and cancer / S.A. Mousa -- Tissue factor pathway inhibitor in thrombosis and beyond / S.A. Mousa [and others] -- Cell adhesion molecules: potential therapeutic and diagnostic implications / S.A. Mousa -- Development and applications of animal models of thrombosis / R.J. Shebuski [and others] -- A survey of venous thrombosis models / W.P. Jeske [and others] -- Arixtra (fondaparinux sodium) / S.A. Mousa -- Oral thrombin inhibitor ximelagatran / S.A. Mousa -- Pharmacogenomics and coagulation disorders / O. Iqbal -- Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism / H. Abdel-Razeq [and others]
- Control code
- 170925939
- Dimensions
- unknown
- Extent
- 1 online resource (x, 307 pages)
- Form of item
- online
- Isbn
- 9781592596584
- Media category
- computer
- Media MARC source
- rdamedia
- Media type code
-
- c
- Other control number
- 10.1385/1592596584
- Other physical details
- illustrations.
- Specific material designation
- remote
- System control number
- (OCoLC)170925939
Subject
- Anticoagulantia
- Anticoagulants (Medicine)
- Anticoagulants (Medicine)
- Anticoagulants (Medicine)
- Anticoagulants -- therapeutic use
- Antitrombotica
- Bloedplaatjes
- Blood platelets
- Blood platelets
- Blood platelets
- Fibrinolytic Agents -- therapeutic use
- Fibrinolytic agents
- Fibrinolytic agents
- Fibrinolytic agents
- Heparin -- therapeutic use
- MEDICAL -- Pharmacology
- Platelet Aggregation Inhibitors -- therapeutic use
- Thrombocytopenia -- drug therapy
- Thrombolytic Therapy -- methods
- Thrombolytic therapy
- Thrombolytic therapy
- Thrombolytic therapy
- Wetenschappelijke technieken
Member of
Library Links
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.missouri.edu/portal/Anticoagulants-antiplatelets-and-thrombolytics/LdwG7DHWYvU/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.missouri.edu/portal/Anticoagulants-antiplatelets-and-thrombolytics/LdwG7DHWYvU/">Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.missouri.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.missouri.edu/">University of Missouri Libraries</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Item Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.missouri.edu/portal/Anticoagulants-antiplatelets-and-thrombolytics/LdwG7DHWYvU/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.missouri.edu/portal/Anticoagulants-antiplatelets-and-thrombolytics/LdwG7DHWYvU/">Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.missouri.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.missouri.edu/">University of Missouri Libraries</a></span></span></span></span></div>
